Literature DB >> 7480672

Hepatic metastases: basic principles and implications for radiologists.

M E Baker1, R Pelley.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7480672     DOI： 10.1148/radiology.197.2.7480672

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  22 in total

1.  Standardisation of liver MDCT by tracking liver parenchyma enhancement to trigger imaging.

Authors:  H Brodoefel; A Tognolini; G A Zamboni; S Gourtsoyianni; C D Claussen; V Raptopoulos
Journal:  Eur Radiol       Date:  2011-11-05       Impact factor: 5.315

2.  EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses.

Authors:  Larissa L Fujii-Lau; Barham K Abu Dayyeh; Marco J Bruno; Kenneth J Chang; John M DeWitt; Paul Fockens; David Forcione; Bertrand Napoleon; Laurent Palazzo; Mark D Topazian; Maurits J Wiersema; Amitabh Chak; Jonathan E Clain; Douglas O Faigel; Ferga C Gleeson; Robert Hawes; Prasad G Iyer; Elizabeth Rajan; Tyler Stevens; Michael B Wallace; Kenneth K Wang; Michael J Levy
Journal:  Gastrointest Endosc       Date:  2015-02-07       Impact factor: 9.427

3.  Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.

Authors:  Steven S Raman; Christopher Leary; David A Bluemke; Marco Amendola; Dushyant Sahani; Jeffrey D McTavish; Jeffrey Brody; Eric Outwater; Donald Mitchell; Douglas H Sheafor; Jeff Fidler; Isaac R Francis; Richard C Semelka; Kohkan Shamsi; Simone Gschwend; David R Feldman; Josy Breuer
Journal:  J Comput Assist Tomogr       Date:  2010 Mar-Apr       Impact factor: 1.826

Review 4.  Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.

Authors:  Stefano Palmucci
Journal:  World J Hepatol       Date:  2014-07-27

Review 5.  Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer.

Authors:  Lourens Bester; Baerbel Meteling; David Boshell; Akshat Saxena; David L Morris
Journal:  Hepat Oncol       Date:  2014-03-20

Review 6.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

7.  [Metastases of colorectal carcinoma].

Authors:  S Clasen; H Rempp; P L Pereira
Journal:  Radiologe       Date:  2008-11       Impact factor: 0.635

Review 8.  Imaging of metastases to the liver.

Authors:  A E Mahfouz; B Hamm; D Mathieu
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

9.  Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma.

Authors:  Jin-Yu Wu; Min-Hua Chen; Wei Yang; Shu-Zhi Lin; Wei Wu; Shan-Shan Yin; Hui Zhang; Kun Yan
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

10.  Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.

Authors:  Eun-A Kim; Kwon-Ha Yoon; Young Hwan Lee; Hye Won Kim; Seon Kwan Juhng; Jong Jin Won
Journal:  Korean J Radiol       Date:  2003 Oct-Dec       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.